top of page

RESEARCH
NOTES

Ecor1 Capital LLC: Activist Profile

EcoR1 Capital is a San Francisco-based fundamental biotechnology-focused investment advisory firm, active in private equity and hedge fund asset classes, established in 2012. The firm evaluates and selects exceptional biotechnology companies, aiming to advance medical research through investments in compelling biotech companies developing promising new solutions for untreated diseases.


Oleg Nodelman

Oleg Nodelman is the Founder and Portfolio Manager of EcoR1 Capital LLC, a biotech-focused investment advisory firm established in 2013 that invests across all stages of research and development. With over 20 years of biotech investing experience, he previously served as a portfolio manager at BVF Partners. Mr. Nodelman is a Board Member of AnaptysBio (NASDAQ: ANAB) and Galapagos (Euronext & NASDAQ: GLPG), both clinical-stage biotechnology companies. He holds a BS in Foreign Service with a focus on Science and Technology from Georgetown University.


Active 13D Positions

Stock

Company name

Sector

% of Portfolio

Link

GLPG

Galapagos NV - ADR

HEALTH CARE

0.2%


1 view0 comments

Recent Posts

See All

Comments


Insight

Insight

Monthly reports

Activism

Research

Research

Subscribe to our newsletter • Don’t miss out!

Anchor 1
Flag on Mountain Peak

Address

Contact

March Intelligence Research LLP,

65, Sakthi Garden, 2nd cross street, Okkiam thoraipakkam, Chennai, Tamilnadu, India

Raghuraman, Founder,  Linkedin

001-9790937345

raghu@snowballresearch.com

snowball research

Value investing  | Qualitative screening

bottom of page